The Board of Directors of Calliditas Therapeutics AB (the “Company”) sets high standards for the Company’s employees, officers and directors. Sound corporate governance is fundamental to this philosophy. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company’s business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
Calliditas Therapeutics is a Swedish public company based in Stockholm.
Corporate governance refers to the systems through which the shareholders, directly or indirectly, control the company. Good corporate governance is an essential component of the work to create value for Calliditas’ shareholders.
Prior to listing on Nasdaq Stockholm, corporate governance in Calliditas was based on Swedish laws and regulations, including the Swedish Companies Act and the Annual Accounts Act, as well as internal rules and regulations.
After the listing, corporate governance is based on the Nasdaq Stockholm Rule Book for Issuers, the Swedish Corporate Governance Code, Good Practice in the Stock Market, and other applicable rules and recommendations. Furthermore, Calliditas also has a number of policy documents and manuals that contain rules and recommendations and provide guidance on the company’s operations and for its employees.